Variant report
Variant | nsv819784 |
---|---|
Chromosome Location | chr13:53703441-53705578 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PCDH8-3 | chr13:53705021-53705956 | XLOC_010625 |
2 | lnc-PCDH8-2 | chr13:53704433-53704475 | NONHSAT034007 |
3 | lnc-PCDH8-4 | chr13:53705020-53705956 | NONHSAT034011 |
4 | lnc-PCDH8-4 | chr13:53705553-53705956 | NONHSAT034013 |
5 | lnc-PCDH8-2 | chr13:53704433-53704701 | XLOC_010624 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543508431 | chr13:53703467-53703468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563287549 | chr13:53703534-53703535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377481907 | chr13:53703550-53703551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546115803 | chr13:53703570-53703571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541950475 | chr13:53703585-53703586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138455056 | chr13:53703598-53703599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548439733 | chr13:53703633-53703634 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568122677 | chr13:53703669-53703670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs74090338 | chr13:53703670-53703671 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs115723109 | chr13:53703747-53703748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570894853 | chr13:53703773-53703774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539904121 | chr13:53703820-53703821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545424972 | chr13:53703821-53703822 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558496474 | chr13:53703881-53703882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565848060 | chr13:53703888-53703889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114261324 | chr13:53703989-53703990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375532769 | chr13:53704021-53704022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73484977 | chr13:53704027-53704028 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs536690749 | chr13:53704028-53704029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375616908 | chr13:53704060-53704061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190261556 | chr13:53704137-53704138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556901720 | chr13:53704176-53704177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575698102 | chr13:53704216-53704217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2181389 | chr13:53704246-53704247 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs370815849 | chr13:53704260-53704261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2491126 | chr13:53704297-53704298 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs138879356 | chr13:53704317-53704318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182580257 | chr13:53704357-53704358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374731806 | chr13:53704384-53704385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368145627 | chr13:53704404-53704405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542118903 | chr13:53704412-53704413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562088427 | chr13:53704416-53704417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188727980 | chr13:53704437-53704438 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs573099835 | chr13:53704442-53704443 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs192976898 | chr13:53704447-53704448 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs564481501 | chr13:53704527-53704528 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs111983544 | chr13:53704543-53704544 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs398037580 | chr13:53704544-53704545 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs201684279 | chr13:53704545-53704546 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs185206622 | chr13:53704555-53704556 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs188928256 | chr13:53704706-53704707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565887245 | chr13:53704711-53704712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4886202 | chr13:53704738-53704739 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs547533914 | chr13:53704778-53704779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs77575874 | chr13:53704780-53704781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538887254 | chr13:53704805-53704806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568399301 | chr13:53704814-53704815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192323780 | chr13:53704826-53704827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs58606612 | chr13:53704859-53704860 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs61374297 | chr13:53704863-53704864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:53696600-53703800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr13:53697800-53709000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr13:53703400-53704000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr13:53703800-53704600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr13:53704000-53704200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
6 | chr13:53704200-53704600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr13:53704600-53705800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |